Vasoactive intestinal peptide: behavioral effects in the rat and hamster

Pharmacol Biochem Behav. 1989 Oct;34(2):387-93. doi: 10.1016/0091-3057(89)90331-6.

Abstract

The behavioral effects of intracerebroventricular (ICV) injection of the brain-gut peptide vasoactive intestinal peptide (VIP) were quantified with a behavioral sampling technique in home-caged, nondeprived, male and female albino rats and golden hamsters. ICV VIP sex-dependently decreased observed resting behavior during 1 hr after injections in both rats and hamsters at 0.1-10.0 micrograms. Grooming behavior was increased in hamsters, and rearing and standing behaviors were increased in rats, sex-dependently at VIP doses that decreased resting. Drinking behavior was suppressed in rats by VIP at 10.0 micrograms. Intraperitoneal (IP) VIP (100.0 micrograms/kg) increased 5% ethanol intake and decreased eating behavior in fluid-deprived male rats. The increase in ethanol intake produced by IP VIP was prevented by IP cholecystokinin octapeptide (CCK, 4.0 micrograms/kg). VIP potently controls resting and ingestive behaviors, suggesting a role for this neuropeptide, along with CCK, in the feedback regulation of rodent behavior.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alcohol Drinking
  • Animals
  • Behavior, Animal / drug effects*
  • Cholecystokinin / pharmacology
  • Cricetinae
  • Ethanol / pharmacology
  • Female
  • Male
  • Rats
  • Vasoactive Intestinal Peptide / pharmacology*

Substances

  • Vasoactive Intestinal Peptide
  • Ethanol
  • Cholecystokinin